We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Platelet Indices Are Associated with Syphilis Activities

By LabMedica International staff writers
Posted on 11 May 2022

Syphilis is caused by Treponema pallidum, which is a chronic sexually transmitted disease that has highly variable clinical courses and manifestations from a painless chancre to severe damage in the brain, heart, and other organs. More...

Platelet indices have been reported as the important mediators in many infectious diseases. Platelet count (PLT), mean platelet volume (MPV), and platelet distribution width (PDW) are the most commonly used indicators to evaluate platelet activation and function.

Venereologists at the Tongji University School of Medicine (Shanghai, China) and their colleagues conducted a retrospective cohort study the Shanghai Skin Disease Hospital from January 2015 to May 2021. A total of 2,061 patients with syphilis (425 primary and secondary syphilis, 433 latent syphilis, 463 serofast syphilis, 350 asymptomatic neurosyphilis, and 390 symptomatic neurosyphilis, respectively) were enrolled. Among them, 209 patients with neurosyphilis were followed until the end of the treatment. In addition, 528 healthy controls were enrolled during the study, with matched age and sex.

The data of platelet count (PLT), mean platelet volume (MPV), platelet distribution width (PDW), and indicators of syphilis activities were collected. The correlations between the platelet indices and disease activities were analyzed. Data of erythrocyte sedimentation rate (ESR), C-reactive protein CRP, serum rapid plasma reagin (RPR), cerebrospinal fluid- venereal disease research laboratory (CSF VDRL), CSF- white blood cell (CSF-WBC) count, and CSF-protein concentration were collected from patients’ medical records.

The scientists reported that compared with the healthy controls, PLT was significantly increased in the primary and secondary syphilis group; whereas, MPV and PDW were significantly decreased in all stages of syphilis. These changes of platelet indices were reversed after anti-treponemal therapy. Further correlation analysis showed that PLT was positively associated with the syphilis activity indicators: RPR titer, CSF-WBC, CSF-protein, and CSF-VDRL and inflammatory markers: WBC, CRP, and ESR. Conversely, PDW was negatively correlated with all of these parameters. MPV had an inverse relationship with RPR, ESR, and CRP.

The authors concluded that their study provided the first evidence that platelet indices are associated with the disease activities in patients with syphilis. As the modification of platelet indices reflects the change of function, this study may suggest the foundation for further elucidation of the underlying mechanism of how platelets participate in the inflammatory response and pathogenesis of syphilis. The study was published on May 1, 2022 in the International Journal of Infectious Diseases.

Related Links:
Tongji University School of Medicine 


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Platelet Function Analyzer
PL-12
Automated Urinalysis Solution
UN-9000
New
Drug Testing Assays
Atellica DT 250 Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: A large, international study led by City of Hope found that the new, investigational liquid biopsy, called PANXEON, was highly sensitive in detecting stage 1 and 2 pancreatic cancer and had a low rate of false positives. The test was also able to identify high-grade dysplasia, a precancerous condition of the pancreas, potentially enabling intervention before cancer develops. (Photo courtesy of City of Hope)

Multi-Biomarker Blood Test Shows Promise for Early Pancreatic Cancer Detection

Pancreatic cancer has the lowest survival rates of any cancer, with only 14% of patients alive five years after diagnosis. The disease is typically discovered after it has spread, and an estimated 90%... Read more

Microbiology

view channel
Image: Graphical Abstract (Jose A. Céspedes, Maria I. Montañez, Isabel M. Jiménez, et al. Magnetic nanoparticles enable clinically relevant in vitro diagnosis of beta-lactam allergy. Materials Today Bio (2026). DOI: 10.1016/j.mtbio.2026.103356)

Magnetic Nanoparticles Enable More Sensitive Beta-Lactam Allergy Testing

Penicillin allergy labels are common in clinical practice, yet many are incorrect and can lead to suboptimal antibiotic choices. Although 8%–25% of people report a penicillin allergy, only 1%–10% are truly... Read more

Technology

view channel
Image: Graphical Abstract (Wenjie Zhang, Zeyu Luo, Kaijie Liu, et al. Science Bulletin, 2026. doi:10.1016/j.scib.2026.09.016)

Multimodal AI Framework Aims to Guide Cancer Immunotherapy Decisions

Cancer immunotherapy has reshaped oncology, but heterogeneous responses and immune-related toxicities continue to complicate routine decision-making. Standard biomarkers, including programmed death-ligand... Read more

Industry

view channel
Image: The acquisition adds Convergent Genomics’ UroAmp platform and proprietary urinary tumor DNA technology to Veracyte’s portfolio (Photo courtesy of Convergent Genomics)

Veracyte Acquisition Expands Urine-Based Bladder Cancer Monitoring Capabilities

Veracyte, Inc. has acquired Convergent Genomics, expanding its urology diagnostics offerings with the company’s UroAmp platform and proprietary urinary tumor DNA (utDNA) technology. UroAmp has been clinically... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.